Arkus Research Private Limited

Arkus Research Private Limited - pharma in South Bopal, Gujarat, India. FY 2026 financials & compliance.
CIN U74140GJ2015PTC084630 Incorporated 30 September 2015 ROC Ahmedabad HQ South Bopal, Gujarat, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹1.07 Cr
▼ 33% YoY
Net loss · FY 2025
₹31.17 Lakh
Net margin -29.1%
EBITDA · FY 2025
-₹39.57 Lakh
EBITDA margin -37%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
11 yrs
Est. 2015
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About Arkus Research Private Limited

Data last updated:

Arkus Research Private Limited is a private limited company based in South Bopal, Gujarat, India. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 30 September 2015 and has been in existence for over 11 years.

The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U74140GJ2015PTC084630. Its GSTIN is 24AANCA8006E1ZX (Gujarat).

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Anupama Ramkumar and Ramkumar Parshuram Subramaniam.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 301 Aaradhya Complex Gala Gymkhana Road, South Bopal, Gujarat, India – 380058.

As per the financials filed for FY 2025, the company reported a revenue of ₹1.07 Cr, a decline of 33% compared to the previous year. For the same year it recorded a net loss of ₹31.17 Lakh (net margin -29.1%) and EBITDA of -₹39.57 Lakh (EBITDA margin -37%). Revenue has declined at a compounded annual rate (CAGR) of 21% over three years and 8% over five years.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U74140GJ2015PTC084630
Registration Number 084630
Incorporation Date 30 September 2015
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant

Contact details

Arkus Research Private Limited's registered office is in South Bopal, Gujarat. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    301 Aaradhya Complex Gala Gymkhana Road, South Bopal, Gujarat, India – 380058
  • Industry
    Pharma, Pharma Contract R&D

To see the full contact details of Arkus Research Private Limited, buy the company report.

Comprehensive company report
Arkus Research Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Arkus Research is professional, scientific and technical. In detail, this covers other professional, scientific and technical activities.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
MProfessional, Scientific and TechnicalM9Other professional, scientific and technical activities

To see the full business activity and turnover split of Arkus Research Private Limited, buy the company report.

Financials of Arkus Research Private Limited

FY 2025 filings available

Arkus Research Private Limited reported revenue of ₹1.07 Cr (down 33% YoY) for FY 2025.

Revenue · FY 2025
₹1.07 Cr ▼ 33%
Net loss · FY 2025
₹31.17 Lakh margin -29.1%
EBITDA · FY 2025
-₹39.57 Lakh margin -37%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 33%
3 years · compounded
▼ 21%
5 years · compounded
▼ 8%
EBITDA CAGR growth
1 year
▼ 311%
3 years · compounded
▼ 34%
5 years · compounded
▼ 23%

Revenue has declined at a compounded annual rate (CAGR) of 8% over five years, including a 33% fall in the latest year. EBITDA fell 311% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹39.57 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹31.17 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin-37%
Net Profit Margin-29.1%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Arkus Research Private Limited, buy the company report.

Board of directors of Arkus Research Private Limited

Arkus Research has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Anupama RamkumarDirector30 Sep 201511 Years 0 MonthsCurrent
Ramkumar Parshuram SubramaniamDirector30 Sep 201511 Years 0 MonthsCurrent

Peer comparison

Arkus Research Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Contract Research), with the same principal business activity (other professional, scientific and technical activities), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Pharmaforce Reports Private Limited₹1.12 Cr (FY 2019)-15.0%Pune, Maharashtra, India
Clinsearch Healthcare Solutions Private Limited₹1.1 Cr (FY 2024)-11.0%Thane, Maharashtra, India
Padm Laboratories Private Limited₹1.09 Cr (FY 2024)-63.0%Bangalore, Karnataka, India
Arkus Research Private Limitedthis company₹1.07 Cr (FY 2025)-₹31.17 Lakh-29.1%-33.0%South Bopal, Gujarat, India

To see the full peer comparison of Arkus Research Private Limited, buy the company report.

Auditor

Arkus Research Private Limited is audited by PANKAJ K SHAH & CO for the financial year 2019.

Auditor firmFinancial yearFirm registration number
PANKAJ K SHAH & COFY 2019107351W

Shareholding

The shareholding of Arkus Research Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2019FY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Arkus Research Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Arkus Research Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Arkus Research has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
24AANCA8006E1ZXGujaratActive01 Jul 2017

To see the full GST registrations and return filing status of Arkus Research Private Limited, buy the company report.

Recent activity

Arkus Research Private Limited has 2 board changes on record since 2015: 2 appointments. The latest: Anupama Ramkumar was appointed as Director on 30 Sep 2015.

AGM
Arkus Research Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Arkus Research Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Appointed
Anupama Ramkumar was appointed as Director.
Appointed
Ramkumar Parshuram Subramaniam was appointed as Director.
Incorporation
30 Sep 2015
Arkus Research Private Limited was registered on 30 Sep 2015 with Roc Ahmedabad & aged 11 years 26 days as per MCA records.

Frequently asked questions

Arkus Research is an active private limited company based in South Bopal, Gujarat, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 30 September 2015 (11+ years old) and is registered under CIN U74140GJ2015PTC084630.

Arkus Research has 2 current directors:

The latest financial statements of Arkus Research on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.

The GSTIN of Arkus Research is 24AANCA8006E1ZX, registered in Gujarat.

The CIN (Corporate Identification Number) of Arkus Research is U74140GJ2015PTC084630. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Arkus Research was incorporated on 30 September 2015, making it 11+ years old. It is registered with the Registrar of Companies, Ahmedabad.

The peers of Arkus Research by revenue are Pharmaforce Reports Private Limited, Clinsearch Healthcare Solutions Private Limited, Padm Laboratories Private Limited, all in the Pharma industry (Contract Research), with the same principal business activity (other professional, scientific and technical activities).

Anupama Ramkumar was appointed as Director on 30 Sep 2015. Ramkumar Parshuram Subramaniam was appointed as Director on 30 Sep 2015.

The registered office of Arkus Research is at 301 Aaradhya Complex Gala Gymkhana Road, South Bopal, Gujarat, India – 380058.

Arkus Research operates in the pharma industry, in the pharma contract r and d segment.

The compliance status of Arkus Research is compliant as of 16 September 2026. The company is actively filing with the Registrar of Companies.